Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (600613.SS)
CNY 7.09
(-0.42%)
CNY 7.09
(-0.42%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 2.31 Billion | 2.38 Billion | 2.3 Billion | 1.81 Billion | 1.92 Billion | 1.85 Billion |
| Cost of Revenue | 1.17 Billion | 1.12 Billion | 916.69 Million | 735.25 Million | 709.9 Million | 723.7 Million |
| Gross Profit | 1.13 Billion | 1.26 Billion | 1.38 Billion | 1.08 Billion | 1.21 Billion | 1.12 Billion |
| Operating Expenses | 1.08 Billion | 1.16 Billion | 1.3 Billion | 1.07 Billion | 1.01 Billion | 978.84 Million |
| Selling, General and Administrative Expenses | 943.85 Million | 1.02 Billion | 1.16 Billion | 951.73 Million | 912.8 Million | 867.56 Million |
| Research and Development Expenses | 32.3 Million | 45.99 Million | 50.94 Million | 42.79 Million | 19.95 Million | 22.84 Million |
| Other Expenses | 70.04 Million | 89.11 Million | 85.13 Million | 77.9 Million | 85.8 Million | -4.03 Million |
| Cost and Expenses | 2.25 Billion | 2.28 Billion | 2.21 Billion | 1.8 Billion | 1.72 Billion | 1.7 Billion |
| Operating Income | 82.83 Million | 105.48 Million | 101.26 Million | 9.44 Million | 197.02 Million | 129 Million |
| Interest Expense | 16.08 Million | 17.36 Million | 8.33 Million | 4.93 Million | 9.12 Million | 10.53 Million |
| Income Tax Expense | 25.14 Million | 15.21 Million | 31.63 Million | 13.19 Million | 27.69 Million | 26.52 Million |
| Earnings before Tax | 83.4 Million | 63.22 Million | 99.59 Million | -340.27 Million | 108.26 Million | 124.96 Million |
| Net Income | 57 Million | 48.54 Million | 69.62 Million | -353.47 Million | 83.97 Million | 106.09 Million |
| Earnings Per Share Basic | 0.11 | 0.09 | 0.13 | -0.66 | 0.16 | 0.20 |
| Earnings Per Share Diluted | 0.11 | 0.09 | 0.13 | -0.66 | 0.16 | 0.20 |
| Weighted Average Shares Outstanding | 518.18 Million | 534.07 Million | 534.07 Million | 533.12 Million | 524.84 Million | 530.45 Million |
| Weighted Average Shares Outstanding (Diluted) | 518.18 Million | 538.63 Million | 535.55 Million | 533.12 Million | 524.84 Million | 530.45 Million |
| Gross Margin | 0.49 | 0.53 | 0.60 | 0.60 | 0.63 | 0.61 |
| EBIT Margin | 0.08 | 0.08 | 0.08 | 0.03 | 0.13 | 0.11 |
| Profit Margin | 0.02 | 0.02 | 0.03 | -0.19 | 0.04 | 0.06 |
| EBITDA | 192.74 Million | 177.02 Million | 176.56 Million | -276.04 Million | 177.82 Million | 172.78 Million |
| Earnings Before Tax Margin | 0.04 | 0.04 | 0.04 | 0.01 | 0.10 | 0.07 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 445.72 Million | 535.83 Million | 564.53 Million | 624.06 Million | 2.31 Billion | 504.86 Million |
| Cost of Revenue | 215 Million | 292.24 Million | 291.96 Million | 354.85 Million | 1.2 Billion | 256.52 Million |
| Gross Profit | 230.71 Million | 243.59 Million | 272.57 Million | 269.2 Million | 1.11 Billion | 248.34 Million |
| Operating Expenses | 204.01 Million | 215.95 Million | 239.92 Million | 273.4 Million | 972.3 Million | 216.29 Million |
| Selling, General and Administrative Expenses | 197.59 Million | 168.2 Million | 230.96 Million | 202.26 Million | - | 232.06 Million |
| Research and Development Expenses | 6.77 Million | 16.15 Million | 8.96 Million | 817.16 Thousand | - | 10.22 Million |
| Other Expenses | 357.71 Thousand | -223.55 Thousand | -361.38 Thousand | -70.31 Million | 1.35 Million | -321.82 Thousand |
| Cost and Expenses | 419.02 Million | 508.19 Million | 531.89 Million | 628.26 Million | 2.17 Billion | 472.81 Million |
| Operating Income | 26.7 Million | 16.15 Million | 32.64 Million | -4.19 Million | 138.88 Million | 30.77 Million |
| Interest Expense | 3.11 Million | 2.63 Million | 3.01 Million | 3.86 Million | 14.76 Million | 3.18 Million |
| Income Tax Expense | 4.96 Million | 2.16 Million | 6.26 Million | 6.47 Million | 25.14 Million | -492.37 Thousand |
| Earnings before Tax | 24.89 Million | 15.93 Million | 31.38 Million | -714.12 Thousand | 83.06 Million | 30.44 Million |
| Net Income | 21.51 Million | 13.89 Million | 23.94 Million | -8.94 Million | 57 Million | 31.21 Million |
| Earnings Per Share Basic | 0.04 | 0.03 | 0.04 | -0.02 | - | 0.06 |
| Earnings Per Share Diluted | 0.04 | 0.03 | 0.04 | -0.02 | - | 0.06 |
| Weighted Average Shares Outstanding | 534.07 Million | 534.07 Million | 534.07 Million | 534.07 Million | 534.07 Million | 490.85 Million |
| Weighted Average Shares Outstanding (Diluted) | 534.07 Million | 534.07 Million | 534.07 Million | 534.07 Million | 534.07 Million | 490.85 Million |
| Gross Margin | 0.52 | 0.45 | 0.48 | 0.43 | 0.48 | 0.49 |
| EBIT Margin | 0.06 | 0.06 | 0.06 | 0.03 | - | 0.07 |
| Profit Margin | 0.05 | 0.03 | 0.04 | -0.01 | 0.02 | 0.06 |
| EBITDA | 28 Million | 31.4 Million | 34.16 Million | 19.22 Million | - | 32.92 Million |
| Earnings Before Tax Margin | 0.06 | 0.03 | 0.06 | -0.01 | 0.06 | 0.06 |
HARRMALAYA
CLBTW
AKSI
EPI-A
TTML
NMR